DRRX
Price
$0.63
Change
+$0.01 (+1.61%)
Updated
Jun 27 closing price
Capitalization
33.11M
YCBD
Price
$0.91
Change
+$0.04 (+4.60%)
Updated
Jun 27 closing price
Capitalization
2.62M
Interact to see
Advertisement

DRRX vs YCBD

Header iconDRRX vs YCBD Comparison
Open Charts DRRX vs YCBDBanner chart's image
DURECT
Price$0.63
Change+$0.01 (+1.61%)
Volume$21.34K
Capitalization33.11M
CBDMD
Price$0.91
Change+$0.04 (+4.60%)
Volume$145.6K
Capitalization2.62M
DRRX vs YCBD Comparison Chart in %
Loading...
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
YCBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRRX vs. YCBD commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRRX is a Hold and YCBD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (DRRX: $0.63 vs. YCBD: $0.91)
Brand notoriety: DRRX and YCBD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DRRX: 17% vs. YCBD: 115%
Market capitalization -- DRRX: $33.11M vs. YCBD: $2.62M
DRRX [@Pharmaceuticals: Other] is valued at $33.11M. YCBD’s [@Pharmaceuticals: Other] market capitalization is $2.62M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRRX’s FA Score shows that 0 FA rating(s) are green whileYCBD’s FA Score has 0 green FA rating(s).

  • DRRX’s FA Score: 0 green, 5 red.
  • YCBD’s FA Score: 0 green, 5 red.
According to our system of comparison, both DRRX and YCBD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRRX’s TA Score shows that 5 TA indicator(s) are bullish while YCBD’s TA Score has 5 bullish TA indicator(s).

  • DRRX’s TA Score: 5 bullish, 5 bearish.
  • YCBD’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, YCBD is a better buy in the short-term than DRRX.

Price Growth

DRRX (@Pharmaceuticals: Other) experienced а -9.51% price change this week, while YCBD (@Pharmaceuticals: Other) price change was +10.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +110.28%. For the same industry, the average monthly price growth was +72.48%, and the average quarterly price growth was +80.22%.

Reported Earning Dates

DRRX is expected to report earnings on May 14, 2025.

YCBD is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+110.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRRX($33.1M) has a higher market cap than YCBD($2.62M). DRRX YTD gains are higher at: -16.507 vs. YCBD (-69.767). YCBD has higher annual earnings (EBITDA): -3.44M vs. DRRX (-33.66M). DRRX has more cash in the bank: 39M vs. YCBD (1.51M). YCBD has less debt than DRRX: YCBD (3.37M) vs DRRX (23.2M). YCBD has higher revenues than DRRX: YCBD (23.4M) vs DRRX (9.19M).
DRRXYCBDDRRX / YCBD
Capitalization33.1M2.62M1,264%
EBITDA-33.66M-3.44M978%
Gain YTD-16.507-69.76724%
P/E RatioN/A0.00-
Revenue9.19M23.4M39%
Total Cash39M1.51M2,591%
Total Debt23.2M3.37M689%
FUNDAMENTALS RATINGS
DRRX vs YCBD: Fundamental Ratings
DRRX
YCBD
OUTLOOK RATING
1..100
2165
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6395
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DRRX's Valuation (55) in the Pharmaceuticals Other industry is in the same range as YCBD (60) in the Other Consumer Services industry. This means that DRRX’s stock grew similarly to YCBD’s over the last 12 months.

DRRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as YCBD (100) in the Other Consumer Services industry. This means that DRRX’s stock grew similarly to YCBD’s over the last 12 months.

DRRX's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as YCBD (100) in the Other Consumer Services industry. This means that DRRX’s stock grew similarly to YCBD’s over the last 12 months.

DRRX's Price Growth Rating (63) in the Pharmaceuticals Other industry is in the same range as YCBD (95) in the Other Consumer Services industry. This means that DRRX’s stock grew similarly to YCBD’s over the last 12 months.

YCBD's P/E Growth Rating (66) in the Other Consumer Services industry is somewhat better than the same rating for DRRX (100) in the Pharmaceuticals Other industry. This means that YCBD’s stock grew somewhat faster than DRRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DRRXYCBD
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
YCBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENR20.240.33
+1.66%
Energizer Holdings
HDSN8.020.13
+1.65%
Hudson Technologies
PW1.110.01
+0.89%
Power REIT
FIVE130.630.71
+0.55%
Five Below
HGBL2.24N/A
N/A
Heritage Global